Experimental Drug Relieves Blast-Related PTSD in a Rat Model of Traumatic Brain Injury
Viviane Callier | Feb 2, 2018
The compound, BCI-838, is already in human clinical trials as a possible treatment for depression.
Neurometabolic Disorders Could Contribute to Depression
Ben Andrew Henry | Nov 1, 2016
Impairments in the production of neurotransmitters may lead to depression in some patients, preliminary results show, opening new avenues for research.
Hot Off the Presses
Bob Grant | Jun 1, 2016
Beyond Biocentrism, The Sting of the Wild, The Birth of Anthropocene, and Ordinarily Well
Zooming In on an Antidepressant Target
Ruth Williams | Apr 6, 2016
Structural studies reveal how SSRI drugs bind to the human serotonin transporter.
Antidepressant Exerts Epigenetic Changes
Anna Azvolinsky | Nov 25, 2015
Molecular markers could aid researchers’ assessment of patient response to the drug.
Antidepressant Could Be Prophylactic for Alzheimer’s
Rina Shaikh-Lesko | May 14, 2014
An SSRI commonly prescribed to treat depression could help prevent the formation of Alzheimer’s disease-associated amyloid plaques.
Ketamine Alternative Shows Promise
Abby Olena | Oct 17, 2013
Researchers show that lanicemine is an effective antidepressant without the adverse effects of the related hallucinogenic drug.
Natural Antidepressant Discovered
Sabrina Richards | Jun 25, 2012
A newly recognized chemical factor in the brain, called neuritin, regulates plasticity and may play a role in depression.
Data Diving
Kerry Grens | May 1, 2012
What lies untapped beneath the surface of published clinical trial analyses could rock the world of independent review.